A one-year randomized double-blind, multicentre study to evaluate the effects of an oestrogen-reduced, continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate and 2 mg dienogest on metabolism in postmenopausal women

By Endrikat Jan   Lange Evelyn   Kunz Michael   Schmidt Werner   Graeser Thomas  

The European Journal of Contraception and Reproductive Health Care, Vol. 12, Iss. 3, 2007-01 ,pp. : 229-239

Informa Healthcare

Access to resources Recommend Favorite

A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolone and continuous combined estrogen-progestogen treatment

By Conner P.   Christow A.   Kersemaekers W.   Söderqvist G.   Skoog L.   Carlström K.   Tani E.   Mol-Arts M.   Schoultz B. von  

Climacteric, Vol. 7, Iss. 1, 2004-01 ,pp. : 50-58

Informa Healthcare

Access to resources Recommend Favorite

A prospective, randomized, double-blind, placebo-controlled study on the influence of a hormone replacement therapy on skin aging in postmenopausal women

By Sator P.-G.   Sator M. O.   Schmidt J. B.   Nahavandi H.   Radakovic S.   Huber J. C.   Honigsmann H.  

Climacteric, Vol. 10, Iss. 4, 2007-08 ,pp. : 320-334

Informa Healthcare

Access to resources Recommend Favorite

Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy

By Pan H.-A.   Wang S.-T.   Chen C.-H.   Pai M.-C.   Wu M.-H.   Huang K.-E.  

Climacteric, Vol. 5, Iss. 3, 2002-09 ,pp. : 259-265

Informa Healthcare

Access to resources Recommend Favorite

A randomized, placebo-controlled trial of the effects of continuous combined hormone replacement therapy on coagulation and fibrinolytic systems in healthy postmenopausal women

By Salobir B.G.u.   Keber I.   Vrabic L.  

Fertility and Sterility, Vol. 78, Iss. 6, 2002-12 ,pp. : 1178-1183

Elsevier

Access to resources Recommend Favorite